<SEC-DOCUMENT>0001104659-20-060162-index.html : 20200512 <SEC-HEADER>0001104659-20-060162.hdr.sgml : 20200512 <ACCEPTANCE-DATETIME>20200512160351 ACCESSION NUMBER: 0001104659-20-060162 CONFORMED SUBMISSION TYPE: DEFA14A PUBLIC DOCUMENT COUNT: 6 FILED AS OF DATE: 20200512 DATE AS OF CHANGE: 20200512 EFFECTIVENESS DATE: 20200512 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Cyclacel Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001130166 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 911766850 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: DEFA14A SEC ACT: 1934 Act SEC FILE NUMBER: 000-50626 FILM NUMBER: 20869047 BUSINESS ADDRESS: STREET 1: 200 CONNELL DRIVE STREET 2: SUITE 1500 CITY: BERKELEY HEIGHTS STATE: NJ ZIP: 07922 BUSINESS PHONE: 908-517-7330 MAIL ADDRESS: STREET 1: 200 CONNELL DRIVE STREET 2: SUITE 1500 CITY: BERKELEY HEIGHTS STATE: NJ ZIP: 07922 FORMER COMPANY: FORMER CONFORMED NAME: XCYTE THERAPIES INC DATE OF NAME CHANGE: 20001218 </SEC-HEADER> <DOCUMENT> <TYPE>DEFA14A <SEQUENCE>1 <FILENAME>tm2019153d2_defa14a.htm <DESCRIPTION>DEFA14A <TEXT> Document 1 - file: tm2019153d2_defa14a.htm
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>2 <FILENAME>tm2019153d2_defa14a-img01.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 2 - file: tm2019153d2_defa14a-img01.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>3 <FILENAME>tm2019153d2_defa14a-img02.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 3 - file: tm2019153d2_defa14a-img02.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>4 <FILENAME>tm2019153d2_defa14a-img03.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 4 - file: tm2019153d2_defa14a-img03.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>5 <FILENAME>tm2019153d2_defa14a-img04.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 5 - file: tm2019153d2_defa14a-img04.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>6 <FILENAME>tm2019153d2_defa14a-img05.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 6 - file: tm2019153d2_defa14a-img05.jpg
</DOCUMENT> </SEC-DOCUMENT>